A series of online, live, public dialogues putting the spotlight on actionable solutions for access to medicines for decision-makers in Europe
EPHA’s series of online discussions on key access to medicines (A2M) priorities brings together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.
Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe.
Find out more about each event:
The Presidencies’ Perspective on the pharmaceutical strategy: Europe’s to-do list on Access to Medicines
Senior representatives of the EU Presidencies of the EU offer their perspectives on the EU’s revision of the Pharmaceutical Strategy.
The EU’s IP strategy: Enabler or barrier?
How do we ensure that IP incentives compensate and reward innovation but do not distort competition? What lessons have we learned on IP in the response to COVID-19?
Unleashing meaningful innovation through regulatory reform
What effect do the shortcomings of current assessment processes have on the quality of innovation? How do we resolve the conundrum of high prices and high uncertainty?
Get the EPHA Newsletter
The best of our activities, right in your inbox!